CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | -96.7% | 109 | -78.2% | 0.00% | -100.0% |
| Q2 2020 | $30,000 | -81.1% | 500 | -80.0% | 0.00% | -75.0% |
| Q1 2020 | $159,000 | +165.0% | 2,500 | -10.7% | 0.01% | +166.7% |
| Q4 2019 | $60,000 | +39.5% | 2,800 | -15.2% | 0.00% | -25.0% |
| Q3 2019 | $43,000 | +230.8% | 3,300 | +153.8% | 0.00% | +300.0% |
| Q1 2019 | $13,000 | -87.3% | 1,300 | -4.1% | 0.00% | -90.0% |
| Q4 2018 | $102,000 | -28.7% | 1,356 | -55.6% | 0.01% | 0.0% |
| Q3 2018 | $143,000 | +90.7% | 3,056 | -45.4% | 0.01% | +100.0% |
| Q2 2018 | $75,000 | +294.7% | 5,600 | +69.7% | 0.01% | +400.0% |
| Q3 2017 | $19,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |